Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
UTHR
UTHR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UTHR News
Surge in Options Volume for AMD and UTHR
1d ago
NASDAQ.COM
Oil Price Surge Drives Significant Stock Movements
1d ago
CNBC
Middle East Tensions Impact Global Markets
1d ago
Benzinga
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
1d ago
Benzinga
United Therapeutics Authorizes $2 Billion Share Repurchase Program
1d ago
NASDAQ.COM
United Therapeutics Announces $2 Billion Stock Repurchase Program
1d ago
seekingalpha
United Therapeutics Authorizes $2 Billion Stock Repurchase Program
1d ago
Yahoo Finance
United Therapeutics Drug Clinical Trial Success
Mar 02 2026
Benzinga
United Therapeutics Achieves Breakthrough in Drug Study
Mar 02 2026
NASDAQ.COM
Ralinepag Phase 3 Study Achieves Key Endpoints
Mar 02 2026
Newsfilter
United Therapeutics Reports Strong Q4 Earnings Exceeding Expectations
Feb 26 2026
Benzinga
United Therapeutics' New Drug Plans Pressure Partner and Rival Stocks
Feb 25 2026
seekingalpha
MannKind Faces Uncertainty Over Tyvaso DPI Royalties
Feb 25 2026
stocktwits
United Therapeutics Q4 2025 Earnings Call Highlights
Feb 25 2026
seekingalpha
United Therapeutics Q4 Earnings Beat Expectations
Feb 25 2026
seekingalpha
United Therapeutics Reports Record Financial Results for 2025
Feb 25 2026
Businesswire
Show More News
